Carter Robert Ross 4/A
4/A · Oncology Institute, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4/AAmended
Carter Robert Ross
Chief Financial Officer
Transactions
- Other
Common Stock
2026-01-02$3.67/sh−244$895→ 235,125 total
Footnotes (1)
- [F1]The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on January 1, 2026.